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Introduction {#bjs550210-sec-0005}
============

Mortality from pancreatic resection has fallen significantly over the past few decades, especially in experienced centres[1](#bjs550210-bib-0001){ref-type="ref"}, [2](#bjs550210-bib-0002){ref-type="ref"}, [3](#bjs550210-bib-0003){ref-type="ref"}. Morbidity, including delayed gastric emptying, anastomotic leak and pancreatic fistula, remains high, affecting around 20--40 per cent of patients[4](#bjs550210-bib-0004){ref-type="ref"}, [5](#bjs550210-bib-0005){ref-type="ref"}, [6](#bjs550210-bib-0006){ref-type="ref"}. Postoperative haemorrhage is less common, but is a life‐threatening event with an estimated mortality rate of 20--50 per cent[7](#bjs550210-bib-0007){ref-type="ref"}, [8](#bjs550210-bib-0008){ref-type="ref"}. Early‐onset haemorrhage is rare, and generally occurs within 24 h, usually due to technical failures. Delayed haemorrhage occurring days or weeks after surgery occurs for a variety of reasons, but one cause of massive haemorrhage is from the formation of visceral arterial pseudoaneurysms. Although several arteries have been shown to be vulnerable to pseudoaneurysm formation, observational studies indicate that pseudoaneurysms of the gastroduodenal artery (GDA) are the most common[9](#bjs550210-bib-0009){ref-type="ref"}, [10](#bjs550210-bib-0010){ref-type="ref"}, [11](#bjs550210-bib-0011){ref-type="ref"}.

The aim of this systematic review was to synthesize existing evidence regarding the incidence, clinical presentation and management of GDA pseudoaneurysms after pancreatic surgery.

Methods {#bjs550210-sec-0006}
=======

Studies evaluating GDA pseudoaneurysm formation after pancreatic surgery were identified by means of database searches of MEDLINE and Embase. In Embase the terms used were: 'false‐aneurysm' AND 'gastroduodenal artery' AND 'pancreaticoduodenectomy' OR 'pancreatectomy' OR 'distal pancreatectomy' OR 'pylorus preserving pancreaticoduodenectomy' OR 'pancreas surgery'. In MEDLINE the terms used were: 'false aneurysm' OR 'pseudoaneurysm' AND 'gastroduodenal artery' AND 'pancreaticoduodenectomy' OR 'pancreas surgery' OR 'pancreatectomy' OR 'distal pancreatectomy' OR 'pylorus preserving pancreaticoduodenectomy'.

A manual reference search was also performed to identify additional observational studies. No language restrictions were applied. Inclusion criteria were: manuscript published in a peer‐reviewed journal until 2017, investigating adult patients aged over 18 years, undergoing pancreatic surgery for any indication, developing GDA pseudoaneurysm, and reporting clinical outcomes of interest. The authors independently reviewed all relevant titles and abstracts, and all disagreements were resolved by consensus. Observational studies that reported both the number of GDA pseudoaneurysms and the total number of pancreatic operations performed were used for quantitative analysis of incidence. Qualitative information also relevant to the clinical presentation and management of GDA pseudoaneurysms was extracted from individual cases and collated. Data extracted included index surgery, sentinel bleeding defined as haemorrhage that occurred in the gastrointestinal tract (intraluminal) or intra‐abdominally (through a surgical drain) between 6 h and 10 days before a massive haemorrhage in the postoperative setting, day of postoperative bleeding, diagnostic method, management, other postoperative complications and mortality. GDA pseudoaneurysms were confirmed either radiologically or during surgery in all studies.

Results {#bjs550210-sec-0007}
=======

A PRISMA flow diagram is shown in *Fig*. [1](#bjs550210-fig-0001){ref-type="fig"}. Some 88 studies were initially identified, 80 were screened, and 29 fulfilled the inclusion criteria. Of these, 13 studies[12](#bjs550210-bib-0012){ref-type="ref"}, [13](#bjs550210-bib-0013){ref-type="ref"}, [14](#bjs550210-bib-0014){ref-type="ref"}, [15](#bjs550210-bib-0015){ref-type="ref"}, [16](#bjs550210-bib-0016){ref-type="ref"}, [17](#bjs550210-bib-0017){ref-type="ref"}, [18](#bjs550210-bib-0018){ref-type="ref"}, [19](#bjs550210-bib-0019){ref-type="ref"}, [20](#bjs550210-bib-0020){ref-type="ref"}, [21](#bjs550210-bib-0021){ref-type="ref"}, [22](#bjs550210-bib-0022){ref-type="ref"}, [23](#bjs550210-bib-0023){ref-type="ref"}, [24](#bjs550210-bib-0024){ref-type="ref"} were not included in the quantification as they were case series dealing exclusively with GDA pseudoaneurysms.

![PRISMA diagram for the review GDA, gastroduodenal artery.](BJS5-3-735-g001){#bjs550210-fig-0001}

Five further studies were excluded as they did not provide the rate of GDA pseudoaneurysm in the postoperative period[25](#bjs550210-bib-0025){ref-type="ref"}, [26](#bjs550210-bib-0026){ref-type="ref"}, [27](#bjs550210-bib-0027){ref-type="ref"}, or the total number of pancreatic operations performed[28](#bjs550210-bib-0028){ref-type="ref"}, [29](#bjs550210-bib-0029){ref-type="ref"}. One study[30](#bjs550210-bib-0030){ref-type="ref"} was excluded because it also included procedures not involving the pancreas (hepatic resection and gastrojejunostomy). Finally, one study[9](#bjs550210-bib-0009){ref-type="ref"} was removed as it recruited patients from the same institution as another report[31](#bjs550210-bib-0031){ref-type="ref"}, but over a shorter period.

All of the nine manuscripts[10](#bjs550210-bib-0010){ref-type="ref"}, [11](#bjs550210-bib-0011){ref-type="ref"}, [31](#bjs550210-bib-0031){ref-type="ref"}, [32](#bjs550210-bib-0032){ref-type="ref"}, [33](#bjs550210-bib-0033){ref-type="ref"}, [34](#bjs550210-bib-0034){ref-type="ref"}, [35](#bjs550210-bib-0035){ref-type="ref"}, [36](#bjs550210-bib-0036){ref-type="ref"}, [37](#bjs550210-bib-0037){ref-type="ref"} selected for quantitative analysis were single‐centre observational studies (*Table*  [1](#bjs550210-tbl-0001){ref-type="table"}), mostly reporting on GDA pseudoaneurysms following pancreatoduodenectomy. One study[33](#bjs550210-bib-0033){ref-type="ref"} included both pancreatoduodenectomy and modified pylorus‐preserving pancreatoduodenectomy, while another[10](#bjs550210-bib-0010){ref-type="ref"} included several pancreatic procedures. Data from 39 patients with GDA pseudoaneurysms were extracted from 14 studies for systematic review of clinical presentation and management (*Table*  [2](#bjs550210-tbl-0002){ref-type="table"}).

###### 

Studies included for determination of incidence

  Reference                                                            Country      Study interval                        Surgical procedures         Total no. of operations   Total no. of GDA pseudoaneurysms   Incidence (%)
  ---------------------------------------------------------------- ---------------- ------------------------------- -------------------------------- ------------------------- ---------------------------------- ---------------
  Adam *et al*.[11](#bjs550210-bib-0011){ref-type="ref"}                Turkey      January 1995 to January 2013                   PD                           342                            7                        2·0
  Suzuki *et al*.[33](#bjs550210-bib-0033){ref-type="ref"}              Japan       January 2012 to July 2016                      PD                           88                             5                         6
  Jeong *et al*.[31](#bjs550210-bib-0031){ref-type="ref"}            South Korea    October 1994 to December 2012                  PD                          1905                            18                       0·9
  Yada *et al*.[32](#bjs550210-bib-0032){ref-type="ref"}                Japan       1982--2010                                 PD + PPPD                        361                            1                        0·3
  Loveček *et al*.[34](#bjs550210-bib-0034){ref-type="ref"}         Czech Republic  2006--2015                                     PD                           449                            1                        0·2
  Fujii *et al*.[10](#bjs550210-bib-0010){ref-type="ref"}               Japan       January 1993 to December 2005    PD + PPPD + DP + SR + HPD + TP             351                            3                        0·9
  Rajarathinam *et al*.[35](#bjs550210-bib-0035){ref-type="ref"}        India       January 1998 to December 2007                  PD                           458                            2                        0·4
  Hur *et al*.[36](#bjs550210-bib-0036){ref-type="ref"}              South Korea    March 2003 to March 2008                       PD                           192                            16                       8·3
  Sato *et al*.[37](#bjs550210-bib-0037){ref-type="ref"}                Japan       January 1992 to December 1997                  PD                           81                             2                         2
  Total                                                                                                                                                        4227                            55                       1·3

GDA, gastroduodenal artery; PD, pancreatoduodenectomy; PPPD, pylorus‐preserving pancreatoduodenectomy; DP, distal pancreatectomy; SR, segmental resection; HPD, pancreatoduodenectomy plus hepatic resection; TP, total pancreatectomy.

###### 

Data extracted for 39 patients with gastroduodenal artery pseudoaneurysm

  Reference                                                         Patient no.                   Age (years)                                     Sex                                Surgery             Complication           Sentinel bleed                       POD of bleed                         Diagnostic method     Management                Survival
  ---------------------------------------------------------------- ------------- --------------------------------------------- ------------------------------------------ ------------------------------ --------------------- ---------------- ------------------------------------------------------ ------------------------ ------------------------ ----------
  Adam *et al*.[11](#bjs550210-bib-0011){ref-type="ref"}                 1                            43                                           M                                    PD               None                        Yes                                  45                                 Angiography        Selective embolization      Yes
  2                                                                     68                             F                                           PD                                Abscess             Yes                          10                             Angiography                        Selective embolization  Yes                      
  3                                                                     59                             M                                           PD                                Abscess             Yes                          4                              Angiography                              TAE of CHA        Yes                      
  4                                                                     41                             M                                           PD                                Abscess             Yes                          23                             Angiography                              TAE of CHA        Yes                      
  5                                                                     63                             M                                           PD                                Abscess             Yes                          14                             Angiography                        Selective embolization  No                       
  6                                                                     72                             F                                           PD                                Abscess             Yes                          25                             Angiography                        Selective embolization  Yes                      
  7                                                                     51                             M                                           PD                                  None              Yes                          7                              Angiography                              TAE of CHA        Yes                      
  Fujii *et al*.[10](#bjs550210-bib-0010){ref-type="ref"}                1                            --                                           --                                  HPD               Pancreatic leak              --                                  10                                 Angiography        TAE of CHA                  Yes
  2                                                                     --                            --                                           PD                           Pancreatic fistula       --                           11                             Angiography                             Relaparotomy       Yes                      
  3                                                                     --                            --                                          HPD                            Pancreatic leak         --                           7                              Angiography                             Relaparotomy       No                       
  Rajarathinam *et al*.[35](#bjs550210-bib-0035){ref-type="ref"}         1                            52                                           M                                    PD               Pancreatic fistula           No                                  17                                 Angiography        Relaparotomy                Yes
  2                                                                     67                             M                                           PD                        Intra‐abdominal abscess     Yes                          17                             Angiography                             Relaparotomy       No                       
  Hur *et al*.[36](#bjs550210-bib-0036){ref-type="ref"}                  1                            --                                           --                                  PPPD              --                           --                                  8                                       --            TAE of CHA                   No
  2                                                                     --                            --                                          PPPD                                  --               --                           6                                   --                                  TAE of CHA        Yes                      
  3                                                                     --                            --                                           PD                                   --               --                           23                                  --                            Selective embolization  Yes                      
  4                                                                     --                            --                                          LPD                                   --               --                           15                                  --                                  TAE of CHA        Yes                      
  5                                                                     --                            --                                          LPD                                   --               --                           7                                   --                            Selective embolization  Yes                      
  6                                                                     --                            --                                          PPPD                                  --               --                           12                                  --                                  TAE of CHA        Yes                      
  7                                                                     --                            --                                          PPPD                                  --               --                           11                                  --                            Selective embolization  No                       
  8                                                                     --                            --                                          PPPD                                  --               --                           7                                   --                                  TAE of CHA        Yes                      
  9                                                                     --                            --                                          PPPD                                  --               --                           8                                   --                                  TAE of CHA        Yes                      
  10                                                                    --                            --                                          PPPD                                  --               --                           19                                  --                                  TAE of CHA        Yes                      
  11                                                                    --                            --                                          PPPD                                  --               --                           7                                   --                                  TAE of CHA        Yes                      
  12                                                                    --                            --                                          PPPD                                  --               --                           19                                  --                                  TAE of CHA        Yes                      
  13                                                                    --                            --                                          PPPD                                  --               --                           8                                   --                                  TAE of CHA        Yes                      
  14                                                                    --                            --                                          PPPD                                  --               --                           14                                  --                                  TAE of CHA        Yes                      
  15                                                                    --                            --                                          HPD                                   --               --                           9                                   --                                  TAE of CHA        Yes                      
  16                                                                    --                            --                                          PPPD                                  --               --                           13                                  --                                  TAE of CHA        Yes                      
  Miyazawa *et al*.[13](#bjs550210-bib-0013){ref-type="ref"}             1                            71                                           M                                    PD               Postoperative bleed          No                                 180                                 Contrast CT        Stenting                    Yes
  Loveček *et al*.[14](#bjs550210-bib-0014){ref-type="ref"}              1                            58                                           M                                    PD               None                        Yes                                  18                                 Angiography        Stenting                    Yes
  Mazza *et al*.[16](#bjs550210-bib-0016){ref-type="ref"}                1                            61                                           M                                   MSR               None                         No                                 210                                 Contrast CT        Selective embolization      Yes
  Huang *et al*.[17](#bjs550210-bib-0017){ref-type="ref"}                1                            72                                           M                                    PD               --                          Yes                                  17                                      --            Selective embolization      Yes
  2                                                                     65                             F                        Duodenum‐preserving pancreatic resection                --               Yes                          30                                  --                            Selective embolization  No                       
  Noun *et al*.[18](#bjs550210-bib-0018){ref-type="ref"}                 1                            58                                           M                                    PD               Pancreatic fistula          Yes                                  19                                 Angiography        Selective embolization      Yes
  Orsenigo *et al*.[21](#bjs550210-bib-0021){ref-type="ref"}             1                            38                                           M                                   SPK               AV fistula                   No                                  15                                MR angiography      Selective embolization      Yes
  Sugimoto *et al*.[22](#bjs550210-bib-0022){ref-type="ref"}             1                            62                                           M                                    PD               None                         No                                 120                                 Angiography        TAE of CHA                  Yes
  Born *et al*.[23](#bjs550210-bib-0023){ref-type="ref"}                 1                            42                                           M                       Lateral pancreatojejunostomy  None                        Yes                                  21                                 Angiography        TAE of CHA                  Yes
  Teramoto *et al*.[24](#bjs550210-bib-0024){ref-type="ref"}             1                            70                                           M                                    PD               Pancreatic leak              No                                  34                                 Angiography        Selective embolization      Yes
  Okuno *et al*.[30](#bjs550210-bib-0030){ref-type="ref"}                1                            46                                           F                                    PD               None                        Yes                                  62                                 Angiography        Selective embolization      Yes
  Overall                                                               39        60[\*](#bjs550210-note-0002){ref-type="fn"}                  16 M, 4 F                                                 14 of 21                  14 of 20      15 (4--210)[\*](#bjs550210-note-0002){ref-type="fn"}                                                     33 of 39

Median (range) value. POD, postoperative day; PD, pancreatoduodenectomy; TAE, transarterial embolization; CHA, common hepatic artery; HPD, pancreatectomy plus hepatic resection; PPPD, pylorus‐preserving pancreatoduodenectomy; LPD, laparoscopic pancreatoduodenectomy; MSR, middle segment resection; SPK, simultaneous pancreas--kidney transplant.

A total of 55 GDA pseudoaneurysms were identified in the postoperative period following 4227 pancreatic procedures, with a reported incidence of 1·3 (range 0·2--8·3) per cent (*Table*  [1](#bjs550210-tbl-0001){ref-type="table"}). Most patients who developed GDA pseudoaneurysm had a preceding complication in the postoperative period (14 of 21), including abscesses (6 patients), pancreatic fistulas (3) and pancreatic leaks (3). Three studies[10](#bjs550210-bib-0010){ref-type="ref"}, [22](#bjs550210-bib-0022){ref-type="ref"}, [38](#bjs550210-bib-0038){ref-type="ref"} reported the formation of pseudoaneurysms away from the cut edge of the pancreas and in the absence of pancreatic fistulas. Sentinel bleeding was reported in 14 of 20 patients (70 per cent). The median time for postoperative haemorrhage was at 15 (range 4--210) days.

Diagnostic procedures were reported for 21 patients; 18 GDA pseudoaneurysms were detected by angiography.

Thirty‐five of the 39 patients (90 per cent) were treated using an endovascular approach. Nineteen (49 per cent) were managed using transarterial embolization (TAE) of the GDA via the common hepatic artery (CHA), and 14 (36 per cent) by selective embolization of the pseudoaneurysm. Stenting was employed in two patients (5 per cent), and only four (10 per cent) were treated by emergency laparotomy. The overall survival rate was 85 per cent (33 of 39).

Discussion {#bjs550210-sec-0008}
==========

The GDA is the most common site for pseudoaneurysm formation after pancreatic surgery[9](#bjs550210-bib-0009){ref-type="ref"}, [10](#bjs550210-bib-0010){ref-type="ref"}, [11](#bjs550210-bib-0011){ref-type="ref"}, and its rupture in the postoperative period has long been recognized as a cause of substantial morbidity and mortality[7](#bjs550210-bib-0007){ref-type="ref"}, [8](#bjs550210-bib-0008){ref-type="ref"}. GDA pseudoaneurysms are rare. The present analysis suggests that they occur in 0·2--8·3 per cent of pancreatic resections. It should be noted, however, that studies included in this review were all high‐volume resectional centres.

In this series, two‐thirds of the patients (4 of 21) had a preceding complication following pancreatic resection. Most authors favoured the hypothesis that lytic, enzyme‐rich, pancreatic fluid from a pancreatic anastomotic leak could result in autodigestion of GDA vessel wall owing to its proximity to the pancreatic anastomosis.

Interestingly, a few studies[10](#bjs550210-bib-0010){ref-type="ref"}, [22](#bjs550210-bib-0022){ref-type="ref"}, [38](#bjs550210-bib-0038){ref-type="ref"} reported the formation of pseudoaneurysms at distance from the pancreatic anastomosis and in the absence of an overt pancreatic fistula, suggesting that minor iatrogenic injury, such as skeletonization of the vessel wall during extensive lymphadenectomy, may lead to vessel weakening and subsequent pseudoaneurysm formation.

Various techniques have been suggested to reduce the chance of pseudoaneurysm formation, including the 'wrapping' technique[25](#bjs550210-bib-0025){ref-type="ref"}, [39](#bjs550210-bib-0039){ref-type="ref"}, [40](#bjs550210-bib-0040){ref-type="ref"}, [41](#bjs550210-bib-0041){ref-type="ref"}, [42](#bjs550210-bib-0042){ref-type="ref"}, [43](#bjs550210-bib-0043){ref-type="ref"}, [44](#bjs550210-bib-0044){ref-type="ref"}, [45](#bjs550210-bib-0045){ref-type="ref"}, in which the exposed retroperitoneal vessels are covered with omentum or the falciform ligament. Others[46](#bjs550210-bib-0046){ref-type="ref"} have suggested leaving 1 cm at the origin of the GDA stump to minimize the likelihood of lytic pancreatic juices coming into contact with the vessel.

Recognition of a sentinel bleed may help in early management, this being a feature in most patients[9](#bjs550210-bib-0009){ref-type="ref"}, [37](#bjs550210-bib-0037){ref-type="ref"}, [47](#bjs550210-bib-0047){ref-type="ref"}. Although sentinel bleeding was associated with poor outcome in some series[6](#bjs550210-bib-0006){ref-type="ref"}, [35](#bjs550210-bib-0035){ref-type="ref"}, few authors discussed the importance of immediate angiography after a sentinel bleed to look for the possibility of a ruptured pseudoaneurysm[6](#bjs550210-bib-0006){ref-type="ref"}, [37](#bjs550210-bib-0037){ref-type="ref"}. Although angiography also has the added benefit of allowing transition to endovascular treatment, a number of reports noted that negative findings cannot be used to exclude a bleeding pseudoaneurysm[26](#bjs550210-bib-0026){ref-type="ref"}, as bleeding can be intermittent or the rate of bleeding is below the detection limit of the equipment[7](#bjs550210-bib-0007){ref-type="ref"}, [9](#bjs550210-bib-0009){ref-type="ref"}, [37](#bjs550210-bib-0037){ref-type="ref"}, [48](#bjs550210-bib-0048){ref-type="ref"}, [49](#bjs550210-bib-0049){ref-type="ref"}.

Surgical intervention has been largely replaced by interventional radiology[50](#bjs550210-bib-0050){ref-type="ref"}, [51](#bjs550210-bib-0051){ref-type="ref"}, [52](#bjs550210-bib-0052){ref-type="ref"}, [53](#bjs550210-bib-0053){ref-type="ref"}, [54](#bjs550210-bib-0054){ref-type="ref"}. Some older studies[26](#bjs550210-bib-0026){ref-type="ref"}, [55](#bjs550210-bib-0055){ref-type="ref"} advocated surgery in the context of additional intra‐abdominal complications such as pancreatic fistula, but more recent series[11](#bjs550210-bib-0011){ref-type="ref"}, [36](#bjs550210-bib-0036){ref-type="ref"} have documented the superiority of endovascular management. A recent meta‐analysis[56](#bjs550210-bib-0056){ref-type="ref"} of non‐randomized studies comparing endovascular management and laparotomy for delayed massive haemorrhage suggested lower complication and mortality rates in the endovascular group.

The endovascular management of pseudoaneurysms varied, reflecting the location and size of the pseudoaneurysm and probably institutional preferences for approach and embolization technique, and materials. TAE of the GDA was conducted via either the CHA or the superior mesenteric artery to achieve both proximal and distal occlusion, to exclude the pseudoaneurysm and prevent backflow from collateral circulation[57](#bjs550210-bib-0057){ref-type="ref"}. Such an approach should consider patency of the portal venous system[41](#bjs550210-bib-0041){ref-type="ref"} as TAE distal and proximal to the GDA pseudoaneurysm can cause complete occlusion of the CHA, leading to liver infarction (reported range 30--66 per cent)[29](#bjs550210-bib-0029){ref-type="ref"}, [37](#bjs550210-bib-0037){ref-type="ref"}, [58](#bjs550210-bib-0058){ref-type="ref"}, as well as hepatic failure and abscess formation[58](#bjs550210-bib-0058){ref-type="ref"}. Covered stents represented the alternative to TAE. The key advantage over TAE would be in maintaining patency of the CHA and reducing the risk of hepatic infarction, although accurate stent deployment might be technically more challenging and time‐consuming than TAE[36](#bjs550210-bib-0036){ref-type="ref"}, [57](#bjs550210-bib-0057){ref-type="ref"}. Despite these issues, stenting seems to be preferred in more recent series, on the grounds that selective embolization of the GDA stump or pseudoaneurysm seems to be associated with high rates of recurrent bleeding[36](#bjs550210-bib-0036){ref-type="ref"}, [42](#bjs550210-bib-0042){ref-type="ref"}.

Limitations of this study include heterogeneity of the included studies, the descriptors used and study sizes. The absence of any prospective registers or clinical trials on this topic needs to be addressed.
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